Propafenone Overdose Lawsuits
Watson Pharmaceuticals issued a Propafenone HCL recall on March 23, 2009, for one lot of 225mg tablets that could contain more of the active drug than they were supposed to. This could lead to a Propafenone overdose, potentially causing serious side effects.
PROPAFENONE RECALL LAWSUIT STATUS: The potential for Propafenone recall lawsuits are being reviewed by lawyers on behalf of individuals who required medical care as a result of problems that may have been caused by receiving too much of the generic heart drug, including low-blood pressure or arrhythmias.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
MANUFACTURER: Watson Phamaceuticals, Inc.
OVERVIEW: On March 23, 2009, a Propafenone recall was issued by generic drug maker Watson Pharmaceuticals, Inc., as some tablets sold in 100 count bottles could be oversized.
The recall applies to one lot of Propafenone HCL 225mg tablets, with lot number 112680A and an expiration date of July 31, 2010.
The recall only applies to this one lot and does not apply to other doses, tablets made by other generic drug makers or the brand name versions of the drug, which are distributed as Rythmol, Rytmonorm and Propafenonum.
PROPAFENONE OVERDOSE: Propafenone HCL (hydrochloride) is a very dose specific medication that has narrow therapeutic index, underlining the importance of patients receiving the proper amount of the drug prescribed by their doctor.
Some patients could be sensitive to even small variations in the dose contained in a tablet, and receiving too much of the mediation could cause serious side effects of propafenone overdose, such as low blood pressure or irregular heart beat.
Symptoms of a low blood pressure or arrhythmia (irregular heartbeat) could include:
- Chest Pain, Palpitations or Pounding in the Chest
- Fainting, Dizzy Feeling or Light Headedness
- Shortness of Breath
Get more articles like this sent directly to your inbox.
"*" indicates required fields
Watson Propafenone HCL Recall Due to Oversized Tablets - AboutLawsuits.comMarch 25, 2009 at 4:31 pm
[...] FDA has posted notice of a Propafenone HCL recall issued by the generic drug maker Watson Pharmaceuticals, Inc., for their 225mg tablets. Some 100 [...]
More Top Stories
A federal magistrate judge has ordered Covidien to turn over a large collection of hernia mesh complaint files to plaintiffs as the parties prepare to select potential bellwether test cases for 2025.
Four federal judges have ruled that the second group of Camp Lejeune lawsuits to be prepared for bellwether trials will involve claims of prostate cancer, kidney disease, lung cancer, liver cancer and breast cancer.
A federal judge has scheduled the initial status conference for coordinated GLP-1 RA drug stomach paralysis lawsuit pretrial proceedings for March 14.